Related Experiment Video
Updated: Nov 3, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
High-sensitivity CRP may be a marker of HDL dysfunction and remodeling in patients with acute coronary syndrome
Xiaoyu Tang1, Ling Mao1, Jin Chen1
1Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital of Central South University, No. 139 Middle Renmin Road, Changsha, 410011, Hunan, China.
Insights
High-density lipoprotein cholesterol (HDL-C) levels do not reflect HDL function in coronary artery disease (CAD) patients. Inflammation marker high-sensitivity C-reactive protein (hsCRP) may indicate impaired cholesterol efflux capacity (CEC) in acute coronary syndrome.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Medical Diagnostics
Background:
- High-density lipoprotein cholesterol (HDL-C) levels are a traditional cardiovascular risk marker.
- Increasing HDL-C has not consistently reduced cardiovascular risk in patients with coronary artery disease (CAD).
- Cholesterol efflux capacity (CEC), a measure of HDL function, may be a better predictor of CAD risk than HDL-C, but its measurement is complex.
Purpose of the Study:
- To explore an easily acquired index for evaluating CEC in CAD patients.
- To investigate the relationship between HDL components, CEC, and inflammation markers in CAD.
- To determine if HDL-C levels reflect HDL function in patients with acute coronary syndrome (ACS).
Main Methods:
- Cross-sectional study of 36 CAD patients (all with ACS) and 61 controls.
- CEC measured using a [3H] cholesterol loading cell model with apolipoprotein B-depleted plasma.
- HDL components and subclass distribution assessed using proton nuclear magnetic resonance (NMR) spectroscopy.
Main Results:
- CEC was significantly lower in CAD patients compared to controls (p=0.022).
- In CAD patients, CEC did not correlate with HDL-C or NMR-determined HDL-C.
- High-sensitivity C-reactive protein (hsCRP) was inversely associated with CEC (r=-0.351, p=0.036) in CAD patients.
- NMR showed larger HDL particles in patients with high hsCRP, accompanied by decreased CEC.
Conclusions:
- In CAD patients, HDL-C levels do not accurately reflect HDL's cholesterol efflux function.
- Inflammation, indicated by hsCRP, may lead to HDL subclass remodeling and dysfunction in ACS.
- hsCRP may serve as a potential indicator of HDL dysfunction in ACS, warranting further investigation.
Abstract:
In patients with coronary artery disease (CAD), further increasing the level of high-density lipoprotein (HDL) cholesterol (HDL-C) as an add-on to statins cannot reduce cardiovascular risk. And it has been reported that HDL functional metric-cholesterol efflux capacity (CEC) may be a better predictor of CAD risk than HDL-C. CEC measurement is time-consuming and not applicable in clinical settings. Thus, it is meaningful to explore an easily acquired index for evaluating CEC. Thirty-six CAD patients and sixty-one non-CAD controls were enrolled in this cross-sectional study. All CAD patients had acute coronary syndrome (ACS). CEC was measured using a [3H] cholesterol loading Raw 264.7 cell model with apolipoprotein B-depleted plasma (a surrogate for HDL). Proton nuclear magnetic resonance (NMR) spectroscopy was used to assess HDL components and subclass distribution. CEC was significantly impaired in CAD patients (11.9 ± 2.3%) compared to controls (13.0 ± 2.2%, p = 0.022). In control group, CEC was positively correlated with enzymatically measured HDL-C levels (r = 0.358, p = 0.006) or with NMR-determined HDL-C levels (NMR-HDL-C, r = 0.416, p = 0.001). However, in CAD group, there was no significant correlation between CEC and HDL-C (r = 0.216, p = 0.206) or NMR-HDL-C (r = 0.065, p = 0.708). Instead, we found that the level of high-sensitivity C-reactive protein (hsCRP) was inversely associated with CEC (r = - 0.351, p = 0.036). Multiple regression analysis showed that the hsCRP level was associated with CEC after adjusting other cardiovascular risk factors and HDL-C, although the association would not reach significance if adjusting for multiple testing. NMR spectroscopy showed that HDL particles shifted to larger ones in patients with high hsCRP levels, and this phenomenon was accompanied by decreased CEC. In patients with CAD, the level of HDL-C cannot reflect HDL function. The impaired correlation between HDL-C and CEC is possibly due to an inflammation-induced HDL subclass remodeling. These hypothesis-generating data suggest that hsCRP levels, a marker of acute inflammation, may associate with HDL dysfunction in ACS subjects. Due to the design limited to be correlative in nature, not permitting causal inference and a larger, strictly designed study is still needed.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations